CHIR-99021三盐酸盐 | 拉格鲁西布三盐酸盐
Laduviglusib trihydrochloride | CHIR-99021 Trihydrochloride
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Laduviglusib trihydrochloride | CHIR-99021 Trihydrochloride
CAS1782235-14-6
FormulaC22H18Cl2N8·3HCl
MW574.72
AppearanceWhite to light yellow powder
Storage condition4°C, sealed storage, away from moisture
Security information
Product details

Laduviglusib (CHIR-99021) trihydrochloride is a potent and selective GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib trihydrochloride shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib trihydrochloride is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib trihydrochloride enhances mouse and human embryonic stem cells self-renewal. Laduviglusib trihydrochloride induces autophagy.


Related literature
Related
Laduviglusib dihydrochloride | CHIR-99021 dihydrochloride | CT99021 dihydrochloride
Laduviglusib monohydrochloride | CHIR-99021 Monohydrochloride | T99021 Monohydrochloride
Laduviglusib (Synonyms: CHIR-99021; CT99021)
History
Nevirapine (BI-RG 587; NSC 641530; NVP)
Laduviglusib trihydrochloride | CHIR-99021 Trihydrochloride
D-Dapoxetine hydrochloride (Synonyms: D-Dapoxetine HCl; LY-210448 hydrochloride)
Elagolix Sodium; NBI 56418NA; NBI-56418 sodium
Siponimod Hemifumarate (Synonyms: BAF-312 Hemifumarate)
Orforglipron hemicalcium hydrate | LY3502970 hemicalcium hydrate | GLP-1 receptor agonist 1 hemicalcium hydrate
Reboxetine | PNU 155950E | Edronax
(Rac)-BL-918
Molibresib besylate (Synonyms: GSK 525762C; I-BET 762 besylate)
Tiagabine | NO050328 | NO328 | TGB